In Hypertension (high blood pressure) Atpure-SA 2.5mg/25mg Tablet is a combination medicine that contains two active ingredients, S-Amlodipine and Atenolol. Both of the medicines in this combination work to lower blood pressure but in different ways. Together they help to relax blood vessels, reduce heart rate and make it easier for your heart to pump blood around your body. This lowers blood pressure. If your blood pressure is controlled you are less at risk of having a heart attack, stroke or kidney problems. The medicine must be taken regularly as prescribed to be effective. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should also make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
It is unsafe to consume alcohol with Atpure
Pregnancy : CONSULT YOUR DOCTOR
SA 2.5mg/25mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life
Breast feeding : CONSULT YOUR DOCTOR
SA 2.5mg/25mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Atpure
Kidney : CAUTION
SA 2.5mg/25mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Atpure
Liver : CAUTION
SA 2.5mg/25mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Atpure
If you miss a dose of Atpure-SA 2.5mg/25mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Aristo Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)